Detecting and quantifying clonal selection in somatic stem cells

Dividing somatic stem cells acquire DNA changes marking different clones. With time, clones can become large, either stochastically through neutral drift, or increased fitness and consequent selection. We present a simple, direct, and general approach that distinguishes between these two processes in normal somatic tissue in individuals. The method relies on single time point whole genome sequencing to study somatic mosaicism as tissues age. Using this method, we show that in human clonal hemopoiesis (CH), clones with CH driver mutations, that comprise a median of 24% of hematopoiesis originate decades before they are detected. They expand, through selection by a median of 26% per year. Overall, there is a 3-fold increased rate of stem cell division and an 8.6-fold increase in active long-term stem cells. One sentence summary We present an approach to distinguish genetic drift from selection, as subclones arise in somatic tissues, in individuals.

[1]  J. Blundell,et al.  Synonymous mutations reveal genome-wide levels of positive selection in healthy tissues , 2021, Nature Genetics.

[2]  M. Stratton,et al.  Extensive phylogenies of human development inferred from somatic mutations , 2021, Nature.

[3]  P. Campbell,et al.  The longitudinal dynamics and natural history of clonal haematopoiesis , 2021, Nature.

[4]  Matthew S. Lebo,et al.  Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection , 2021, Nature Medicine.

[5]  S. Dawson,et al.  HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults , 2021, Nature Medicine.

[6]  P. Campbell,et al.  Lineage tracing of human development through somatic mutations , 2021, Nature.

[7]  M. Stratton,et al.  Development, maturation, and maintenance of human prostate inferred from somatic mutations , 2021, Cell stem cell.

[8]  Johannes G. Reiter,et al.  Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis , 2021, Cell.

[9]  Martin L. Miller,et al.  Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases , 2020, Nature Communications.

[10]  J. Vijg,et al.  Pathogenic Mechanisms of Somatic Mutation and Genome Mosaicism in Aging , 2020, Cell.

[11]  S. Mccarroll,et al.  Chromosomal alterations among age-related haematopoietic clones in Japan , 2020, Nature.

[12]  A. Álvarez-Buylla,et al.  Maintenance of neural stem cell positional identity by mixed-lineage leukemia 1 , 2020, Science.

[13]  T. Druley,et al.  The evolutionary dynamics and fitness landscape of clonal hematopoiesis , 2020, Science.

[14]  Inigo Martincorena,et al.  Somatic mutations and clonal dynamics in healthy and cirrhotic human liver , 2019, Nature.

[15]  M. Stratton,et al.  The landscape of somatic mutation in normal colorectal epithelial cells , 2018, Nature.

[16]  M. Stratton,et al.  The mutational landscape of normal human endometrial epithelium , 2018, bioRxiv.

[17]  Peter J. Campbell,et al.  Population dynamics of normal human blood inferred from somatic mutations , 2018, Nature.

[18]  Stanley W. K. Ng,et al.  Prediction of acute myeloid leukaemia risk in healthy individuals , 2018, Nature.

[19]  Yakir A Reshef,et al.  Insights about clonal hematopoiesis from 8,342 mosaic chromosomal alterations , 2018, Nature.

[20]  Chuang Tan,et al.  Universal Patterns of Selection in Cancer and Somatic Tissues , 2018, Cell.

[21]  H. Ohtsuki,et al.  Forward and backward evolutionary processes and allele frequency spectrum in a cancer cell population. , 2017, Theoretical population biology.

[22]  Kari Stefansson,et al.  Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. , 2017, Blood.

[23]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[24]  Marc J. Williams,et al.  Quantification of subclonal selection in cancer from bulk sequencing data , 2018, Nature Genetics.

[25]  Marc J. Williams,et al.  Identification of neutral tumor evolution across cancer types , 2016, Nature Genetics.

[26]  E. Zeggini,et al.  Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis , 2015, Cell reports.

[27]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[28]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[29]  Joshua F. McMichael,et al.  Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.

[30]  G. Parmigiani,et al.  Heterogeneity of genomic evolution and mutational profiles in multiple myeloma , 2014, Nature Communications.

[31]  Mithat Gonen,et al.  Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.

[32]  J. Berg,et al.  Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.

[33]  P. Opolon,et al.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.

[34]  O. Abdel-Wahab,et al.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.

[35]  Subhajyoti De,et al.  Somatic mosaicism in healthy human tissues. , 2011, Trends in genetics : TIG.

[36]  Allon M Klein,et al.  Intestinal Stem Cell Replacement Follows a Pattern of Neutral Drift , 2010, Science.

[37]  Hans Clevers,et al.  Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem Cells , 2010, Cell.